AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
COMPLEX APOLIPOPROTEIN B-CONTAINING LIPOPROTEIN PARTICLES ARE ASSOCIATED WITH A HIGHER RATE OF PROGRESSION OF HUMAN CHRONIC RENAL-INSUFFICIENCY
Authors: SAMUELSSON O ATTMAN PO KNIGHTGIBSON C LARSSON R MULEC H WEISS L ALAUPOVIC P
Citation: O. Samuelsson et al., COMPLEX APOLIPOPROTEIN B-CONTAINING LIPOPROTEIN PARTICLES ARE ASSOCIATED WITH A HIGHER RATE OF PROGRESSION OF HUMAN CHRONIC RENAL-INSUFFICIENCY, Journal of the American Society of Nephrology, 9(8), 1998, pp. 1482-1488
THE COMPOSITIONAL ABNORMALITIES OF LIPOPROTEINS IN DIABETIC RENAL-FAILURE
Authors: ATTMAN PO KNIGHTGIBSON C TAVELLA M SAMUELSSON O ALAUPOVIC P
Citation: Po. Attman et al., THE COMPOSITIONAL ABNORMALITIES OF LIPOPROTEINS IN DIABETIC RENAL-FAILURE, Nephrology, dialysis, transplantation, 13(11), 1998, pp. 2833-2841
EFFECT OF THYROID-HORMONE ON PLASMA APOLIPOPROTEINS AND APOA-CONTAINING AND APO-B-CONTAINING LIPOPROTEIN PARTICLES
Authors: LIU XQ RAHMAN A BAGDADE JD ALAUPOVIC P KANNAN CR
Citation: Xq. Liu et al., EFFECT OF THYROID-HORMONE ON PLASMA APOLIPOPROTEINS AND APOA-CONTAINING AND APO-B-CONTAINING LIPOPROTEIN PARTICLES, European journal of clinical investigation, 28(4), 1998, pp. 266-270
HOMOCYSTEINE IS ELEVATED IN RENAL-INSUFFICIENCY BUT IT DOES NOT PREDICT THE RATE OF PROGRESSION
Authors: LEE DM SAMUELSSON O ATTMAN PO KNIGHTGIBSON C MULLEN K LARSSON R MULEC H WEISS LG ALAUPOVIC P
Citation: Dm. Lee et al., HOMOCYSTEINE IS ELEVATED IN RENAL-INSUFFICIENCY BUT IT DOES NOT PREDICT THE RATE OF PROGRESSION, Circulation, 98(17), 1998, pp. 209-209
NEW LIPOPROTEIN PREDICTORS OF RECURRENT CORONARY EVENTS - VLDL PARTICLE CONCENTRATION, VLDL LIPID-CONTENT, AND APOLIPOPROTEIN-CIII AND APOLIPOPROTEIN-E
Authors: SACKS FM ALAUPOVIC P MOYE LA COLE TG STAMPFER MJ BRAUNWALD E
Citation: Fm. Sacks et al., NEW LIPOPROTEIN PREDICTORS OF RECURRENT CORONARY EVENTS - VLDL PARTICLE CONCENTRATION, VLDL LIPID-CONTENT, AND APOLIPOPROTEIN-CIII AND APOLIPOPROTEIN-E, Circulation, 98(17), 1998, pp. 4145-4145
USE APOLIPOPROTEIN PARAMETERS AND END-POINTS IN DRUG DEVELOPMENT AND APPROVAL PROCESSES
Authors: ALAUPOVIC P
Citation: P. Alaupovic, USE APOLIPOPROTEIN PARAMETERS AND END-POINTS IN DRUG DEVELOPMENT AND APPROVAL PROCESSES, The American journal of cardiology, 81(8A), 1998, pp. 40-47
EFFICACY AND SAFETY OF A NEW HYDROXYMETHYLGLUTARYL-COENZYME A REDUCTASE INHIBITOR, ATORVASTATIN, IN PATIENTS WITH COMBINED HYPERLIPIDEMIA -COMPARISON WITH FENOFIBRATE
Authors: OOI TC HEINONEN T ALAUPOVIC P DAVIGNON J LEITER L LUPIEN PJ SNIDERMAN AD TAN MH TREMBLAY G SORISKY A SHURZINSKE L BLACK DM
Citation: Tc. Ooi et al., EFFICACY AND SAFETY OF A NEW HYDROXYMETHYLGLUTARYL-COENZYME A REDUCTASE INHIBITOR, ATORVASTATIN, IN PATIENTS WITH COMBINED HYPERLIPIDEMIA -COMPARISON WITH FENOFIBRATE, Arteriosclerosis, thrombosis, and vascular biology, 17(9), 1997, pp. 1793-1799
THE ROLE OF TRIGLYCERIDE-RICH LIPOPROTEIN FAMILIES IN THE PROGRESSIONOF ATHEROSCLEROTIC LESIONS AS DETERMINED BY SEQUENTIAL CORONARY ANGIOGRAPHY FROM A CONTROLLED CLINICAL-TRIAL
Authors: ALAUPOVIC P MACK WJ KNIGHTGIBSON C HODIS HN
Citation: P. Alaupovic et al., THE ROLE OF TRIGLYCERIDE-RICH LIPOPROTEIN FAMILIES IN THE PROGRESSIONOF ATHEROSCLEROTIC LESIONS AS DETERMINED BY SEQUENTIAL CORONARY ANGIOGRAPHY FROM A CONTROLLED CLINICAL-TRIAL, Arteriosclerosis, thrombosis, and vascular biology, 17(4), 1997, pp. 715-722
APOLIPOPROTEIN AND LIPID-COMPOSITION OF LIPOPROTEIN DENSITY CLASSES IN DIALYSIS PATIENTS
Authors: MOBERLY JB ATTMAN PO SAMUELSSON O KNIGHTGIBSON C ALAUPOVIC P
Citation: Jb. Moberly et al., APOLIPOPROTEIN AND LIPID-COMPOSITION OF LIPOPROTEIN DENSITY CLASSES IN DIALYSIS PATIENTS, Journal of the American Society of Nephrology, 8, 1997, pp. 1025-1025
LIPOPROTEIN ABNORMALITIES ARE ASSOCIATED WITH INCREASED RATE OF PROGRESSION OF HUMAN CHRONIC RENAL-INSUFFICIENCY
Authors: SAMUELSSON O MULEC H KNIGHTGIBSON C ATTMAN PO KRON B LARSSON R WEISS L WEDEL H ALAUPOVIC P
Citation: O. Samuelsson et al., LIPOPROTEIN ABNORMALITIES ARE ASSOCIATED WITH INCREASED RATE OF PROGRESSION OF HUMAN CHRONIC RENAL-INSUFFICIENCY, Nephrology, dialysis, transplantation, 12(9), 1997, pp. 1908-1915
PROGRESSION OF RENAL-FAILURE - ROLE OF APOLIPOPROTEIN B-CONTAINING LIPOPROTEINS
Authors: ATTMAN PO SAMUELSSON O ALAUPOVIC P
Citation: Po. Attman et al., PROGRESSION OF RENAL-FAILURE - ROLE OF APOLIPOPROTEIN B-CONTAINING LIPOPROTEINS, Kidney international, 1997, pp. 98-101
THE EFFECT OF AGGRESSIVE LOWERING OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS AND LOW-DOSE ANTICOAGULATION ON OBSTRUCTIVE CHANGES IN SAPHENOUS-VEIN CORONARY-ARTERY BYPASS GRAFTS
Authors: CAMPEAU L KNATTERUD GLMK DOMANSKI M HUNNINGHAKE DB WHITE CW GELLER NL ROSENBERG Y HERD A COCANOUGHER MK DUNN K FARMER J FOREYT J GREGORY K INSULL W JACKSON M KLEIMAN N LEWIS R LLOYD C MARESH K MATTHEW C MINOR S ROBERTS R SALMON A SHACKELFORD P STEWART R THOMPSON M YOUNG J GUINN A HARRIS G HEIBIG J LEVY VV FORRESTER J HICKEY A BUCHBINDER N DAVIDSON R DRURY K EBER L EIGLER N GEFT I GOLDBERG S GRODAN P HENDEL J HIGGINS S HODGSON T HUGHES L KARLSBERG R KATZ J LEPOR N LITVAK F LUPTAK Y MADERA G MARCUS H MONDKAR A NEIDORF B NEUMANN M NIVATPUMIN T RABINOWITZ Y RAYMOND M READER A RURYCZ V SCHAPIRA J SCHLANGER J SILVERBERG R SMITH A TABAK S VALOVIS R GRAY R HOOGWERF B STEWART W BAERVEDT G BOTTSILVERMAN C BREEN C BUCKNER P CABRAL J CRESSMAN M FONSECA C FOSTER J FOSTER R GUTMAN F HARRIS L HEUPLER F HOBBS R HUANG S KALENAK J KASSEM M KOSMORSKY G KRAMER J KURZAWA C LANGSTON R LINCOFF M LINDBERG J LOWDER C MCCAFFERTY F MCKEOWN D MEISLER D MENDLOVIC D MEYERS S MOORE J NOUSEK J RAYMOND R RINCON G ROBIN J ROCKWOOD E SHELDON W SIMPFENDORFER C WALSH H WANESS A WRIGHT K YANAK F GOULET C BEDARD H BOIS M BUJOLD S COTE G DAVIGNON J DEBELDER M DUCHARME AM DOUCET S DUMAS J DYDRA I FOUCHER S CREPEAU J GOSSELIN G GROULX D JOYAL M JUNEAU M LESPERANCE J LEVESQUE C LEVESQUE J MARCIL M OLIVIER M PASTERNAC A POITRAS AM POITRAS D QUEVILLON A RIOUX C ROBITAILLE D SISOUPHONE K SOLYMOSS C HUNNINGHAKE D CHRISTIANSON B DIANGELIS N GARDNER K HELGREN R IACARELLA C KNOBLOCH W LAU L LAXSON D LEON A LONDON E MANION R MCDONALD K MCGINN A MIANULLI M ROBINSON J TURNER G WANG Y WHITE C WILSON R ZIMMER S GOBEL F ANDERSON P BAUMGARD C CHRISTENSEN J FULCO A HANSON K JOHNSON C LARSON B MADISON J MCCORMACK P OSTROV C PECHA R PEDERSON W PIER T RANDALL M RODMAN W ROELLER S SCOTT K SHER N SPEILMAN J THOMPSON R ZUPFER S GOLDENBERG I HEALY B KNATTERUD G TERRIN M CANNER M FICK S FORMAN S HANSON D HOWARD J HUANG AL KARABELAS S LOPRESTI F MERCER W RA K RANDALL A SCHACTMAN M SCHLEIGH B SNIDER R MIRENZI E FISHER M FOX NL CZAJKOWSKI S GELLER N PROBSTFIELD J SHUMAKER S WITTES J YUSUF S ZUCKER D CARTLAND J DAS G MEYER S POWERS T RINGDAL D ROSZA Z SHAHEEN B SIREK M STONE C SNIDER J VANYI J ALAUPOVIC P FESMIRE J WALENGA J BERMES E HOPPENSTEADT D PIFARRE R CARLETON R BAILEY K BRODY B CAIRNS J FURBERG C FUSTER V GRONDIN C JENKINS D LAROSA J MEIER P
Citation: L. Campeau et al., THE EFFECT OF AGGRESSIVE LOWERING OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS AND LOW-DOSE ANTICOAGULATION ON OBSTRUCTIVE CHANGES IN SAPHENOUS-VEIN CORONARY-ARTERY BYPASS GRAFTS, The New England journal of medicine, 336(3), 1997, pp. 153-162
EFFECT OF GEMFIBROZIL ON LIPOPROTEIN ABNORMALITIES IN CHRONIC RENAL-INSUFFICIENCY - A CONTROLLED-STUDY IN HUMAN CHRONIC RENAL-DISEASE
Authors: SAMUELSSON O ATTMAN PO KNIGHTGIBSON C KRON B LARSSON R MULEC H WEISS L ALAUPOVIC P
Citation: O. Samuelsson et al., EFFECT OF GEMFIBROZIL ON LIPOPROTEIN ABNORMALITIES IN CHRONIC RENAL-INSUFFICIENCY - A CONTROLLED-STUDY IN HUMAN CHRONIC RENAL-DISEASE, Nephron, 75(3), 1997, pp. 286-294
LIPOLYTIC RATE OF TRIGLYCERIDE-RICH LIPOPROTEINS IN RENAL-INSUFFICIENCY DEPENDS ON THE COMPOSITION OF NEUTRAL LIPIDS AND APOLIPOPROTEINS
Authors: LEE DM GIBSON CK SAMUELSSON O WANG CS ATTMAN PO ALAUPOVIC P
Citation: Dm. Lee et al., LIPOLYTIC RATE OF TRIGLYCERIDE-RICH LIPOPROTEINS IN RENAL-INSUFFICIENCY DEPENDS ON THE COMPOSITION OF NEUTRAL LIPIDS AND APOLIPOPROTEINS, Atherosclerosis, 134(1-2), 1997, pp. 346-346
RELATIVE IMPORTANCE OF APOE IN CHOLESTEROL EFFLUX
Authors: NAZIH H REMALEY A HANNUKSELA M MEYN SM KINDT MR ALAUPOVIC P BREWER HB
Citation: H. Nazih et al., RELATIVE IMPORTANCE OF APOE IN CHOLESTEROL EFFLUX, Atherosclerosis, 134(1-2), 1997, pp. 378-378
EFFECT OF A NEW HMG-COA REDUCTASE INHIBITOR, ATORVASTATIN, ON LIPIDS,APOLIPOPROTEINS AND LIPOPROTEIN PARTICLES IN PATIENTS WITH ELEVATED SERUM-CHOLESTEROL AND TRIGLYCERIDE LEVELS
Authors: ALAUPOVIC P HEINONEN T SHURZINSKE L BLACK DM
Citation: P. Alaupovic et al., EFFECT OF A NEW HMG-COA REDUCTASE INHIBITOR, ATORVASTATIN, ON LIPIDS,APOLIPOPROTEINS AND LIPOPROTEIN PARTICLES IN PATIENTS WITH ELEVATED SERUM-CHOLESTEROL AND TRIGLYCERIDE LEVELS, Atherosclerosis, 133(1), 1997, pp. 123-133
THE IN-VIVO METABOLISM OF APOLIPOPROTEIN E-CONTAINING HIGH-DENSITY-LIPOPROTEINS
Authors: HANNUKSELA ML MEYN SM TALLEY GD NAZIH H BADER G SHAMBUREK RD ALAUPOVIC P BREWER HB
Citation: Ml. Hannuksela et al., THE IN-VIVO METABOLISM OF APOLIPOPROTEIN E-CONTAINING HIGH-DENSITY-LIPOPROTEINS, Circulation, 96(8), 1997, pp. 4053-4053
DIFFERENT ACTION OF TRIGLYCERIDE-RICH AND CHOLESTEROL-RICH APO B-CONTAINING LIPOPROTEINS ON PROGRESSION OF RENAL-FAILURE
Authors: SAMUELSSON O KNIGHTGIBSON C LARSSON R MULEC H WEISS L ALAUPOVIC P ATTMAN PO
Citation: O. Samuelsson et al., DIFFERENT ACTION OF TRIGLYCERIDE-RICH AND CHOLESTEROL-RICH APO B-CONTAINING LIPOPROTEINS ON PROGRESSION OF RENAL-FAILURE, Journal of the American Society of Nephrology, 7(9), 1996, pp. 391-391
PLASMA-LEVELS OF LIPOPROTEIN (A) DO NOT PREDICT PROGRESSION OF HUMAN CHRONIC-RENAL-FAILURE
Authors: SAMUELSSON O ATTMAN PO KNIGHTGIBSON C LARSSON R MULEC H WEDEL H WEISS L ALAUPOVIC P
Citation: O. Samuelsson et al., PLASMA-LEVELS OF LIPOPROTEIN (A) DO NOT PREDICT PROGRESSION OF HUMAN CHRONIC-RENAL-FAILURE, Nephrology, dialysis, transplantation, 11(11), 1996, pp. 2237-2243
ABNORMAL LIPID AND APOLIPOPROTEIN COMPOSITION OF MAJOR LIPOPROTEIN DENSITY CLASSES IN PATIENTS WITH CHRONIC-RENAL-FAILURE
Authors: ATTMAN PO ALAUPOVIC P TAVELLA M KNIGHTGIBSON C
Citation: Po. Attman et al., ABNORMAL LIPID AND APOLIPOPROTEIN COMPOSITION OF MAJOR LIPOPROTEIN DENSITY CLASSES IN PATIENTS WITH CHRONIC-RENAL-FAILURE, Nephrology, dialysis, transplantation, 11(1), 1996, pp. 63-69
DIAGNOSIS AND CLASSIFICATION OF DYSLIPIDEMIA IN RENAL-DISEASE
Authors: ATTMAN PO SAMUELSSON O ALAUPOVIC P
Citation: Po. Attman et al., DIAGNOSIS AND CLASSIFICATION OF DYSLIPIDEMIA IN RENAL-DISEASE, Blood purification, 14(1), 1996, pp. 49-57
ALTERATIONS IN PLASMA-LIPOPROTEINS AND APOLIPOPROTEINS BEFORE THE AGEOF 40 IN HETEROZYGOTES FOR LIPOPROTEIN-LIPASE DEFICIENCY
Authors: BIJVOET S GAGNE SE MOORJANI S GAGNE C HENDERSON HE FRUCHART JC DALLONGEVILLE J ALAUPOVIC P PRINS M KASTELEIN JJP HAYDEN MR
Citation: S. Bijvoet et al., ALTERATIONS IN PLASMA-LIPOPROTEINS AND APOLIPOPROTEINS BEFORE THE AGEOF 40 IN HETEROZYGOTES FOR LIPOPROTEIN-LIPASE DEFICIENCY, Journal of lipid research, 37(3), 1996, pp. 640-650
TRIGLYCERIDE ENRICHED LIPOPROTEIN PARTICLES CORRELATE WITH THE SEVERITY OF CORONARY-ARTERY DISEASE
Authors: KOREN E CORDER C MUELLER G CENTURION H HALLUM G FESMIRE J MCCONATHY WD ALAUPOVIC P
Citation: E. Koren et al., TRIGLYCERIDE ENRICHED LIPOPROTEIN PARTICLES CORRELATE WITH THE SEVERITY OF CORONARY-ARTERY DISEASE, Atherosclerosis, 122(1), 1996, pp. 105-115
APOLIPOPROTEIN-E - THE DIFFERENTIAL EFFECT OF APOE AND LPE PARTICLES IN CHOLESTEROL EFFLUX
Authors: NAZIH H REMALEY AT ALAUPOVIC P BREWER HB
Citation: H. Nazih et al., APOLIPOPROTEIN-E - THE DIFFERENTIAL EFFECT OF APOE AND LPE PARTICLES IN CHOLESTEROL EFFLUX, Circulation, 94(8), 1996, pp. 3039-3039
REDUCTION IN CAROTID ARTERIAL-WALL THICKNESS USING LOVASTATIN AND DIETARY THERAPY - A RANDOMIZED, CONTROLLED CLINICAL-TRIAL
Authors: HODIS HN MACK WJ LABREE L SELZER RH LIU CR LIU CH ALAUPOVIC P KWONGFU H AZEN SP
Citation: Hn. Hodis et al., REDUCTION IN CAROTID ARTERIAL-WALL THICKNESS USING LOVASTATIN AND DIETARY THERAPY - A RANDOMIZED, CONTROLLED CLINICAL-TRIAL, Annals of internal medicine, 124(6), 1996, pp. 548
Risultati: 1-25 | 26-34